ARCHIVES

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

This article is from The Cancer Letter archive.

Vol. 28 No. 46 | December 13, 2002

Download PDF Visit The Full Archive

Related Articles

Ten Cooperative Group Chairs Propose Eight “Guiding Principles” For Change

May 20, 2011

In Brief: Surgical Oncology Program Announcements Due For Publication By June; AACR/ASCO Program

April 17, 1981

The Cancer Letter Marks 25th Anniversary

December 18, 1998

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

Vitamin D Not Associated With Risk For Less Common Cancers, Study Finds

July 30, 2010

Aspirin Use Associated With Lower Cancer Indicence, Death

April 27, 2007